IMMUNOLOGY 2022, May 2022
Proteomic analysis of plasma exosomes as biomarkers of response to MVP-S based immunotherapy
Scientific Reports, February 2021
Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model
Brennan S. Dirk, Genevieve Weir, Tara Quinton, Olga Hrytsenko, Marianne M. Stanford